With the analysis among 48 patents, we discovered top 16 key players by total patent application. Procella Therapeutics AB, Edwards Lifesciences Corp., HD Biosciences Co., Ltd. are dominant in this area. They take 62.50% of the total patent filing.
California, United States
Patent: 6
Shanghai Shi, China
Patent: 2
California, United States
Patent: 2
Jilin Sheng, China
Patent: 2
Basel-Stadt, Switzerland
Patent: 1
Hitachi High-Tech America, Inc.
Illinois, United States
Patent: 1
No data, please try another search term
With the analysis among related 27 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Procella Therapeutics AB, Yantai Yuhuangding Hospital, Primax Medica Sp zoo take 48.15% of patent filing during this period.
Shandong Sheng, China
Patent: 2
Liaoning Sheng, China
Patent: 1
Shaanxi Sheng, China
Patent: 1
Linghao Medical Technology (Tianjin) Co., Ltd.
Tianjin Shi, China
Patent: 1
Beijing Institute of Heart Lung & Blood Vessel Diseases
With the analysis among related 27 patents in last 5 years, we discover 13 new entrants. Yantai Yuhuangding Hospital, Primax Medica Sp zoo, Shenyang Polytechnic University are the most active new entrants in this area.
Shandong Sheng, China
Patent: 2
Liaoning Sheng, China
Patent: 1
Shaanxi Sheng, China
Patent: 1
Linghao Medical Technology (Tianjin) Co., Ltd.
Tianjin Shi, China
Patent: 1
Beijing Institute of Heart Lung & Blood Vessel Diseases
With the analysis among 26 patents, we discovered top 11 universities and scientific research institutions by total patent application. Fudan University, China Pharmaceutical University, Boston University are dominant in this area. They take 42.31% of the total patent filing.
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 2
Massachusetts, United States
Patent: 1
Shaanxi Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
Hubei Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Henan Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
Liaoning Sheng, China
Patent: 1